ArticleJournal of cardiovascular translational research2025
Identification of Candidate Inflammatory-Nutritional Blood Biomarkers for Cachexia and Muscle Depletion in Polish Chronic Heart Failure Patients.
Article in Journal of cardiovascular translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cachexia is a complex syndrome often affecting chronic heart failure (CHF) patients, characterized by muscle wasting and systemic inflammation. Early detection is crucial for improving patient outcomes. This study evaluated candidate inflammatory and nutritional biomarkers, including a novel C-reactive protein-to-albumin ratio (CAR) modification adjusted for body mass index (CARB), in predicting cachexia and muscle depletion in CHF patients. By analyzing 154 newly diagnosed CHF patients, 25 candidate inflammatory-nutritional biomarkers were examined. Muscle depletion parameters (fat-free mass-FFM, fat-free mass index-FFMI, appendicular lean mass-ALM, appendicular skeletal muscle-ASM) were assessed using bioelectrical impedance analysis and the Global Leadership Initiative on Malnutrition (GLIM) criteria. CARB was found to be the most significant predictor of cachexia (OR = 4.89) and muscle mass reduction (OR = 2.450 for FFMI; OR = 3.530 for ASMI). CARB demonstrated excellent diagnostic accuracy (AUC = 0.930) and is a promising candidate biomarker for predicting cachexia and muscle depletion in CHF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.